CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 23 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,000 | 0.0% | 1,857 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | -50.0% | 1,857 | 0.0% | 0.00% | – |
| Q1 2015 | $2,000 | +100.0% | 1,857 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | -83.3% | 1,857 | 0.0% | 0.00% | -100.0% |
| Q3 2014 | $6,000 | 0.0% | 1,857 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $6,000 | -14.3% | 1,857 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $7,000 | – | 1,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 250,000 | $920,000 | 0.42% |
| Rotella Capital Management, Inc. | 19,639 | $72,000 | 0.09% |
| Invesco Private Capital | 116,316 | $428,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 26,500 | $97,000 | 0.01% |
| Allianz Asset Management GmbH | 559,207 | $2,058,000 | 0.00% |
| North Star Investment Management Corp. | 1,857 | $7,000 | 0.00% |
| UBS AG | 1,000 | $4,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 4,300 | $16,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 26,712 | $98,000 | 0.00% |
| NORTHERN TRUST CORP | 32,991 | $121,000 | 0.00% |